Pyogenic lung infections: Factors for predicting clinical outcome of lung abscess and thoracic empyema

Current Opinion in Pulmonary Medicine

Volumn 6, Issue 3, 2000, Pages 234-239

  Mwandumba, Henry C ^a   Beeching, Nicholas J ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABSCESS DRAINAGE; HUMAN; IMMUNE RESPONSE; INFECTION RISK; LUNG ABSCESS; LUNG INFECTION; PLEURA EMPYEMA; PLEURA FLUID; REVIEW;

EID: 0033925379     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200005000-00012     Document Type: Review

References (45)

1. 1 Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR for the Empyema Subcommittee of the Research Committee of the British Thoracic Society: The clinical course and management of thoracic empyema. Quart J Med 1996, 89:285-289.
2. 2 Hagan JL, Hardy JD: Lung abscess revisited: a survey of 184 cases. Ann Surg 1983, 197:755-762.
3. 3 Bartlett JG, Gorbach SL: Treatment of aspiration pneumonia and primary lung abscess, penicillin G vs. clindamycin. JAMA 1975, 234:935-937.
4. 4 Schweppe HI, Knowles JH, Kane L: Lung abscess: an analysis of the Massachusetts General Hospital cases from 1943 through 1956. N Engl J Med 1961, 265:1039-1043.
5. 5 Weiss W, Cherniack NS: Acute nonspecific lung abscess: a controlled study comparing orally and parentally administered penicillin G. Chest 1974, 66:348-351.
6. 6 Chidi CC, Mendelsohn HJ: Lung abscess: a study of the results of treatment based on 90 consecutive cases. J Thorac Cardiovasc Surg 1974, 68:186-172.
7. 7 Estrera AS, Platt MR, Mills LF, Shaw RR: Primary lung abscess. J Thorac Cardiovasc Surg 1980, 78:275-282.
8. 8 Delarue NC, Person FG, Nelems JM, Cooper JD: Lung abscess: surgical implications. Can J Surg 1980, 23:297-302.
9. 9 Pohlson EC, McNamara JJ, Char C, Kurata L: Lung abscess: a changing pattern of the disease. Am J Surg 1985, 150:97-101.
10. 10 Perlman LV, Lerner E, D'Esposo N: Clinical classification and analysis of 97 cases of lung abscess. Am Rev Resp Dis 1969, 99:390-398.
11. 11 Mori T, Ebe T, Takahashi M, et al.: Lung abscess: analysis of 66 cases from 1979 to 1991. Intern Med (Tokyo) 1993, 32:278-284.
12. 12 Harber P, Terry PB: Fatal lung abscesses: review of 11 years' experience. South Med J 1981, 74:281-283.
13. 13 Furman AC, Jacobs F, Sepkowitz KA: Lung abscess in patients with AIDS. Clin Infect Dis 1996, 22:81-85.
14. 14 Barnett TB, Herring CL: Lung abscess: initial and late results of medical therapy. Arch Intern Med 1971, 127:217-227.
15. 15 Neild JE, Eykyn SJ, Phillips I: Lung abscess and empyema. Quart J Med 1985, 224:875-882.
16. 16 Hirshberg B, Sklair-Levi M, Nir-Paz R, Ben-Sira L, Krivoruk V, Kramer MR: Factors predicting mortality of patients with lung abscess. Chest 1999, 115:746-750. This retrospective review describes some factors associated with increased mortality in patients with lung abscess.
17. 17 Bartlett JG: Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993, 16(suppl 4):S248-S255.
18. 18 Hammond JMJ, Potgieter PD, Hanslo D, Scott H, Roditi D: The aetiology and antimicrobial susceptibility patterns of microorganisms in acute community acquired lung abscess. Chest 1995, 108:937-941.
19. 19 Gudiol F, Manresa F, Pallares R, Dorca J, Rufi G, Boada J, et al.: Clindamycin vs penicillin for anaerobic lung infections: high rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990, 150:2525-2529.
20. 20 Levison ME, Mangura CT, Lorber B, Abrutyn E, Pesanti EL, Levy RS, et al.: Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 1983, 98:466-359.
21. 21 Irwin RS, Garrity FL, Erickson AD, Corrao WM, Kaemmerlen JT: Sampling lower respiratory tract secretions in primary lung abscess: a comparison of the accuracy of four methods. Chest 1981, 79:559-565.
22. 22 Bartlett JG: Treatment of anaerobic pleuropulmonary infections. Ann Intern Med 1975, 83:376-377.
23. 23 Lubitz RM: Resolution of lung abscess due to Pseudomonas aerugmosa with oral ciprofloxacin: case report. Rev Infect Dis 1990, 12:757-759.
24. 24 Kaye MG, Fox MJ, Bartlett JG, Braman SS, Glassroth J: The clinical spectrum of Staphylococcus aureus pulmonary infections. Chest 1990, 97:788-792.
25. 25 Lorber B, Swenson RM: Bacteriology of aspiration pneumonia. A prospective study of community-and hospital-acquired cases. Ann Intern Med 1974, 81:329-331.
26. 26 Liaw Y-S, Yang P-C, Wu Z-G, Yu C-J, Chang D-B, Lee L-N, et al.: The bacteriology of obstructive pneumonitis: a prospective study using ultrasound-guided transthoracic needle aspiration. Am J Respir Crit Care Med 1994, 149:1648-1653.
27. 27 Sahn SA: Management of complicated parapneumonic effusion. Am Rev Respir Dis 1993, 148:813-817.
28. 28 Hamm H, Light RW: Parapneumonic effusion and empyema. Eur Respir J 1997, 10:1150-1156.
29. 29 Lee-Chiong TL Jr: Treating empyema without surgery. Postgrad Med 1997, 101:195-204.
30. 30 Cham CW, Haq SM, Rahamim J: Empyema thoracis: a problem with late referral? Thorax 1993, 48:925-927.
31. 31 Pothula V, Krellenstein DJ: Early aggressive management of parapneumonic empyemas. Chest 1994, 105:832-836.
32. 32 Alfageme I, Munoz, F, Pena N, Umbria S: Empyema of the thorax in adults: etiology, microbiologic findings and management. Chest 1993, 103:839-843.
33. 33 Lindstrom ST, Kolbe J: Community acquired parapneumonic thoracic empyema: predictors of outcome. Respirology 1999, 4:173-179. A good retrospective review of predictors of outcome in community-acquired thoracic empyema.
34. 34 Sahn SA, Light RW: The sun should never set on a parapneumonic effusion. Chest 1989, 95:945-946.
35. 35 Ashbaugh DG: Empyema thoracic: factors influencing morbidity and mortality. Chest 1991, 99:1162-1165.
36. 36 Heffner JE, McDonald J, Barbieri C, Klein J: Management of parapneumonic effusions: an analysis of physician practice patterns. Arch Surg 1995, 130:433-438.
37. 37 Heffner JE: Indications for draining a parapneumonic effusion: an evidence based approach. Semin Respir Infect 1999, 14:48-58. An excellent, evidence-based review on the indications for draining a parapneumonic effusion.
38. 38 Light RW, Rodriguez RM: Management of parapneumonic effusions. Clin Chest Med 1998, 19:373-382.
39. 39 Braman SS, Donat WE: Explosive pleuritis: manifestation of group A beta-haemolytic streptococcal infection. Am J Med 1986, 81:723-726.
40. 40 Torres A, Serra-Batlles J, Ferrer A, Jimenez P, Celis R, Cobo E, Rodriguez-Roisin R: Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991, 114:312-318.
41. 41 Huang H-C, Chang H-Y, Chen C-W, Lee C-H, Hsiue T-R: Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion or empyema. Chest 1999, 115:751-756. This retrospective review attempts to identify factors associated with poor outcome of tube thoracostomy.
42. 42 LeMense GP, Strange C, Sahn SA: Empyema thoracic: therapeutic management and outcome. Chest 1995, 107:1532-1537.
43. 43 Brook I, Frazier EH: Aerobic and anaerobic microbiology of empyema: a retrospective review in two military hospitals. Chest 1993, 103:1502-1507.
44. 44 Boland GW, Lee MJ, Silverman S, Mueller PR: Interventional radiology of the pleural space. Clin Radiol 1995, 50:205-214.
45. 45 Stark DD, Federle MP, Goodman PC: CT and radiographic assessment of tube thoracostomy. AJR Am J Roentgenol 1983, 141:253-258.